SCHEMBL10384056

SCHEMBL10384056

CCOC(=O)[C@H](CSCCSC1CCCCC1)NC(C)C(=O)N1CCC[C@H]1C(=O)OC

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 11/20 0.48
▸ LMNA P02545 2/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ PEPD P12955 2/20 0.37
▸ XPNPEP1 Q9NQW7 1/20 0.37
▸ FKBP1A P62942 3/20 0.36
▸ POLB P06746 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ABCB11 O95342 1/20 0.34
▸ PDE3A Q14432 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10384057 1.00 ACE (0.48) ACELMNASMN1; SMN2PEPDXPNPEP1
SCHEMBL10384147 0.99 ACE (0.49) ACELMNASMN1; SMN2PEPDXPNPEP1
SCHEMBL10384148 0.99 ACE (0.49) ACELMNASMN1; SMN2PEPDXPNPEP1
SCHEMBL10383739 0.92 ACE (0.58) ACELMNASMN1; SMN2PEPD
SCHEMBL10383735 0.92 ACE (0.58) ACELMNASMN1; SMN2PEPD
SCHEMBL10523169 0.92 ACE (0.52) ACELMNASMN1; SMN2PEPDXPNPEP1
SCHEMBL10523157 0.92 ACE (0.52) ACELMNASMN1; SMN2PEPDXPNPEP1
SCHEMBL10383741 0.91 ACE (0.58) ACELMNASMN1; SMN2PEPD
SCHEMBL10384301 0.91 ACE (0.58) ACELMNASMN1; SMN2PEPD
SCHEMBL10523907 0.91 ACE (0.52) ACELMNASMN1; SMN2PEPDXPNPEP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4977179-A Inhibiting angiotensin converting enzyme OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1990-12-11 — — US claimed
US-4977179-A Inhibiting angiotensin converting enzyme OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1990-12-11 — — US disclosed
Send feedback